Prevalence of chronic hepatitis B and hepatitis C among first time blood donors in northeast Bosnia and Herzegovina: An estimate of prevalence in general population

Hepatitis Monthly

Volumn 11, Issue 8, 2011, Pages 629-633

  Petrovic, Jasminka ^a   Salkic, Nermin N ^a   Ahmetagic, Sead ^a   Stojic, Vildana ^a   Mott Divkovic, Slavica ^a  

^a UNIVERSITY CLINICAL CENTER TUZLA   (Bosnia and Herzegovina)

Author keywords

Blood donors; Bosnia and Herzegovina; Hepatitis B; Hepatitis C virusm epidemiology; Population

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MALE; SEROPREVALENCE; SEX DIFFERENCE; SEX RATIO;

EID: 80052602361     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.1506     Document Type: Article

References (25)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97-107.
2. Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29(Suppl 1):74-81.
3. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529-38.
4. Ahmetagic S, Hantalasevic L, Tihic N, Jusufovic E, Stojic V. Hepatitis C virus infection in hemodialysis patients in General Hospital Gracanica. Med Arh. 2006;60(5):298-300.
5. Ahmetagic S, Muminhodzic K, Cickusic E, Stojic V, Petrovic J, Tihic N. Hepatitis C infection in risk groups. Bosn J Basic Med Sci. 2006;6(4):13-7.
6. Ahmetagic S, N NS, Cickusic E, Zerem E, Mott-Divkovic S, Tihic N, et al. Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in northeastern Bosnia and Herzegovina. Bosn J Basic Med Sci. 2009;9(4):278-82.
7. Salkic NN, Zildzic M, Muminhodzic K, Pavlovic-Calic N, Zerem E, Ahmetagic S, et al. Intrafamilial transmission of hepatitis B in Tuzla region of Bosnia and Herzegovina. Eur J Gastroenterol Hepatol. 2007;19(2):113.
8. Breslow NE, Day NE. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ. 1987;(82):1-406.
9. Doll R, Cook P. Summarizing indices for comparison of cancer incidence data. Int J Canc. 1967;2(3):269-79.
10. Goritsas C, Plerou I, Agaliotis S, Spinthaki R, Mimidis K, Velissaris D, et al. HCV infection in the general population of a Greek island: prevalence and risk factors. Hepatogastroenterology. 2000;47(33):782-5.
11. Grgicevic D, Balija M, Pirc-Tiljak D, Mihaljevic I, Gjenero-Margan I, Zupancic-Salek S, et al. Decreasing risk of viral transfusion-transmitted diseases in Croatia. Croat Med J. 2000;41(2):191-6.
12. Fejza H, Telaku S. Prevalence of HBV and HCV among blood donors in Kosovo. Virol J. 2009;6:21.
13. Seo DH, Whang DH, Song EY, Kim HS, Park Q. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion. 2011;[Epub ahead of print].
14. Yuen MF, Ka-Ho Wong D, Lee CK, Tanaka Y, Allain JP, Fung J, et al. Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis. 2011;52(5):624.
15. Gossop M, Strang J, Griffiths P, Powis B, Taylor C. A ratio estimation method for determining the prevalence of cocaine use. Br J Psychiatry. 1994;164(5):676-9.
16. Marconi A, Candido S, Talamini R, Libra M, Nicoletti F, Spandidos D, et al. Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey. Mol Med Report. 2010;3(4):561.
17. Soldan K, Barbara JA, Ramsay ME, Hall AJ. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang. 2003;84(4):274-86.
18. Gay NJ, Hesketh LM, Osborne KP, Farrington CP, Morgan-Capner P, Miller E. The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect. 1999;122(1):133-8.
19. Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13(27):3730-3.
20. Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM. Sytematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr. 2007;44(9):663-74.
21. Koulentaki M, Spanoudakis S, Kantidaki E, Drandakis P, Tzagarakis N, Biziagos E, et al. Prevalence of hepatitis B and C markers in volunteer blood donors in Crete. A 5-year study. J Viral Hepat. 1999;6(3):243-8.
22. Durro V, Koraqi A, Saliasi S. Trends in the prevalence of transfusiontransmissible infections among blood donors in Albania. Clin Lab. 2010;56(11-12):591-5.
23. Kondili LA, Ulqinaku D, Hajdini M, Basho M, Chionne P, Madonna E, et al. Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection. Infection. 2007;35(2):94-7.
24. Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L, et al. HBV, HCV and HIV seroprevalence among blood donors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies? Braz J Infect Dis. 2010;14(1):41-6.
25. Pirnar A, Kanra T. Incidence and distribution of hepatitis Bs-antigen in Turkey. Vox Sang. 1976;31(1):67-9.